Preoperative prostate MRI exams can offer added value in predicting biochemical recurrence (BCR) of prostate cancer and often perform comparably to post-surgical pathologic staging. That’s according to new data published in the American Journal of Roentgenology, comparing the utility of pre-surgical staging information from MRI and post-surgical staging information from radical prostatectomy (RP) pathology in...

Prostate cancer remains the second deadliest cancer for men despite clinical advancements. Currently, Magnetic Resonance Imaging (MRI) is considered the most sensitive non-invasive imaging modality that enables visualisation, detection and localisation of prostate cancer, and is increasingly used to guide targeted biopsies for prostate cancer diagnosis. However, its utility remains limited due to high rates...

Source: Metastatic prostate cancer cases surged following the issuance of U.S. Preventive Services Task Force recommendations against routine screening for the disease, according to research published Monday. It was back in 2008 that the influential panel of experts urged against regular prostate-specific antigen testing among men older than 75, which spread to all ages by...

Source: Researchers at Karolinska Institutet in Sweden, together with international collaborators, have completed a comprehensive international validation of artificial intelligence (AI) for diagnosing and grading prostate cancer.

Using multiparametric MRI (mpMRI) to image men suspected of having prostate cancer can reduce unnecessary biopsies by more than a third and increase the detection of clinically significant disease by more than 50%. By Kate Madden Yee, AuntMinnie.com staff writer

“Integration of a scoring system into structured prostate MRI reports could be of great value to clinical research as well as routine clinical care..." Matt O'Connor | Imaging Informatics | Health Imaging